Compare Multifiling Mitra Indonesia Tbk. (MFMI) vs Prodia Widyahusada Tbk. (PRDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multifiling Mitra Indonesia Tbk. vs Prodia Widyahusada Tbk. — how do they compare? Multifiling Mitra Indonesia Tbk. trades at Rp1,300 (market cap 984.86B), while Prodia Widyahusada Tbk. trades at Rp2,810 (market cap 2.63T, 861.1K 24h volume). The key difference: Prodia Widyahusada Tbk. is far larger — about 2.7× Multifiling Mitra Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MFMI | PRDA | |
|---|---|---|
Market Cap | 984.86B | 2.63T |
Volume | — | 861.1K |
Lot | — | 8.61K |
Turnover | — | 2.42B |
Average Price | — | 2,806.54 |
Value | — | 2.42B |
Indicative Equilibrium Price | — | 2,810 |
Indicative Equilibrium Volume | — | 713 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multifiling Mitra Indonesia Tbk.
PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.
Read more on MFMI →About Prodia Widyahusada Tbk.
PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →
